China NT Pharma Shareholders to Vote June 28 on Proposed Share Consolidation

MT Newswires Live06-07

Shareholders of China NT Pharma Group (HKG:1011) will meet June 28 to vote on a proposed 10-for-1 share consolidation and a change in board lot size, a Friday filing with the Hong Kong bourse said.

The drugmaker plans to consolidate every 10 issued and unissued existing shares, as well as convertible preference shares, into one consolidated or convertible preference share.

Following consolidation, the companyâs authorized share capital will be $50,100 divided into roughly 62.6 billion consolidated shares and 32.5 million consolidated convertible preference shares, each with a par value of $0.0000008.

Following the consolidation becoming effective, the company proposes to change the board lot size for trading on the bourse to 10,000 consolidated shares with a value of roughly HK$2,200 from 500 existing shares currently.

Shares of the company closed 9% lower on Friday.

Price (HKD): $0.02, Change: $, Percent Change: -9.09%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2441505770?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-07 20:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2441505770","market":"us","top_or_hot":-1,"title":"China NT Pharma Shareholders to Vote June 28 on Proposed Share Consolidation","media":"MT Newswires Live","content":"<html><body><p> Shareholders of China NT Pharma Group (HKG:1011) will meet June 28 to vote on a proposed 10-for-1 share consolidation and a change in board lot size, a Friday filing with the Hong Kong bourse said. </p><p>The drugmaker plans to consolidate every 10 issued and unissued existing shares, as well as convertible preference shares, into one consolidated or convertible preference share. </p><p>Following consolidation, the companyâs authorized share capital will be $50,100 divided into roughly 62.6 billion consolidated shares and 32.5 million consolidated convertible preference shares, each with a par value of $0.0000008.</p><p>Following the consolidation becoming effective, the company proposes to change the board lot size for trading on the bourse to 10,000 consolidated shares with a value of roughly HK$2,200 from 500 existing shares currently.</p><p>Shares of the company closed 9% lower on Friday. </p><p>Price (HKD): $0.02, Change: $, Percent Change: -9.09%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China NT Pharma Shareholders to Vote June 28 on Proposed Share Consolidation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina NT Pharma Shareholders to Vote June 28 on Proposed Share Consolidation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-07 20:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shareholders of China NT Pharma Group (HKG:1011) will meet June 28 to vote on a proposed 10-for-1 share consolidation and a change in board lot size, a Friday filing with the Hong Kong bourse said. ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4023","symbol_name":"应用软件","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2441505770","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2441505770","pubTimestamp":1717762224,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shareholders of China NT Pharma Group (HKG:1011) will meet June 28 to vote on a proposed 10-for-1 share consolidation and a change in board lot size, a Friday filing with the Hong Kong bourse said. Th","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4023":"应用软件","01011":"泰凌医药","HKD":"尚乘数科","BK1191":"制药","BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4526":"热门中概股"},"translate_title":"中国泰凌医药股东将于6月28日就拟议股份合并进行投票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HKD":1,"01011":0.9},"content_text":"Shareholders of China NT Pharma Group (HKG:1011) will meet June 28 to vote on a proposed 10-for-1 share consolidation and a change in board lot size, a Friday filing with the Hong Kong bourse said. The drugmaker plans to consolidate every 10 issued and unissued existing shares, as well as convertible preference shares, into one consolidated or convertible preference share. Following consolidation, the companyâs authorized share capital will be $50,100 divided into roughly 62.6 billion consolidated shares and 32.5 million consolidated convertible preference shares, each with a par value of $0.0000008.Following the consolidation becoming effective, the company proposes to change the board lot size for trading on the bourse to 10,000 consolidated shares with a value of roughly HK$2,200 from 500 existing shares currently.Shares of the company closed 9% lower on Friday. Price (HKD): $0.02, Change: $, Percent Change: -9.09%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2441505770"}